NSF Patient Sues over MRI Contrast Agent
Chesterfield, MO: A man who claims to have suffered from
MRI contrast side effects and MRI health risks has launched a lawsuit against the hospital that administered a series of MRI procedures that eventually left him with early-stage Nephrogenic Systemic Fibrosis (NSF).
[READ MORE]
Amiodarone and Simvastatin Anything But a Dynamic Duo
Kansas City, MO: The relationship between simvastatin and amiodarone, together with the
amiodarone interaction identified as simvastatin rhabdomyolysis, came to the forefront in August of last year when the FDA issued an alert to health care professionals regarding the risk for rhabdomyolysis when simvastatin is used in association with amiodarone.
[READ MORE]
Man Sues Hospital After Developing Nephrogenic Systemic Fibrosis
St. Louis, MO: A lawsuit was filed today on behalf of a man who developed a rare disorder called nephrogenic systemic fibrosis (NSF) after he was injected with gadolinium-based contrast agents for
magnetic resonance imaging (MRI) at St. Luke’s Hospital in Chesterfield, MO.
[READ MORE]